Lang Research Center

Research at New York Hospital Queens

The Lang Center for Research and Education was established in 2001 at New York Hospital Queens. A strong research and education program stimulates a culture that fosters excellence in clinical care. Our goal is to create new knowledge by conducting cutting-edge clinical research and to integrate excellent clinical care with research and education.

Click here to read about the George F. Heinrich, M.D. Symposium Diabetes 2010: From Public Policy to Target Organs.

Our Mission

It is our mission to provide a research infrastructure that will facilitate the conduct of clinical research at New York Hospital Queens. This includes securing research funding from outside sources (government, industry, foundation), providing statistical and grant writing assistance, as well as coordinating needs from various departments so that resources can be utilized with maximum benefit to all.

Research Projects

There are 120 other research studies currently in progress at New York Hospital Queens. State-of-the-art treatments are being tested by physicians and other professional staff in the areas of kidney disease, cancer, heart failure, radiation oncology, pediatrics, and obstetrics, just to name a few. New York Hospital Queens is at the forefront of new treatments for West Nile Virus, HIV, and Hepatitis C.

Recent highlight:

• Phyllis August, M.D., M.P.H., is a co-author and co-investigator of a landmark study called BARI 2D (Bypass Revascularization Investigation 2 Diabetes), published in June 2009 in the "New England Journal of Medicine." The Lang Research Center was one of the sites that conducted the NIH-sponsored study. The study involved 49 clinical sites worldwide.

Research Training Program

Among the center’s efforts are a training program for medical residents and fellows that allows physicians-in-training to conduct a clinical research study and culminates in Residents and Fellows Day, a symposium that showcases the studies and includes the presentation of Lang Research Awards, chosen by the hospital’s Scientific Advisory Board.

The 2009 winning studies were presented in formats that included posters, oral presentations and case reports, and topics covered radiation oncology, cardiology and gastroenterology:

• Nya Ebama, M.D.: “Wenckebach Block and Thyrotoxic Periodic Paralysis: Case Report and Review of Literature”
• Joshua E. Meyer, M.D.: “Radiation Therapy Increases Survival in Surgically Treated Localized Invasive Thymomas and Thymic Carcinomas: An Analysis of the SEER Database” 
• Sofya Kostanyan, M.D.: “Relationship Between Augmentation Pressure and LDL Cholesterol Levels In Normotensive Subjects” 
• Amreen Dinani, M.D.: “Sustainability of a Performance Improvement Project: Inappropriate Use of GI Prophylaxis in Non-ICU Hospitalized Patients” 
• Jason Gluck, M.D.: “Variability of Arterial Supply to the Inferior Myocardial Wall” 

Most recently, the center hosted a unique conference on “Diagnosing Breast Cancer in Multi-Ethnic Communities,” an event that brought together researchers and clinicians from across New York City to discuss why there appear to be differences in the occurrence, diagnosis and management of breast cancer, particularly among Asian women.

We firmly believe that participating in the evaluation of new treatments benefits patients, doctors and the hospital. For more information regarding clinical trials of new therapies at New York Hospital Queens, please call Karen Hultberg at (718) 670-2840.